NOVADAQ Enters Into Agreement to be Acquired by Stryker Corporation
Jun 19, 2017 12:00 pm UTC| Business
TORONTO, June 19, 2017 -- NOVADAQ Technologies Inc. (NASDAQ:NVDQ) (TSX:NDQ) (“NOVADAQ” or the “Corporation”), the leading provider of proven comprehensive fluorescence imaging solutions that improve clinical outcomes...
Jun 19, 2017 12:00 pm UTC| Business
TEL AVIV, Israel, June 19, 2017 -- VBL Therapeutics (Nasdaq:VBLT) provided an update on the long term status and survival of patients from three completed Phase 2 trials, which investigated the company’s lead candidate,...
Inovio Pharmaceuticals to Participate on Panel at 2017 BIO International Convention
Jun 19, 2017 12:00 pm UTC| Business
PLYMOUTH MEETING, Pa., June 19, 2017 -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that Dr. J. Joseph Kim, President CEO, will participate on a panel, titled “Platform Technologies: The Key to Responding...
IPG Photonics Announces Agreement to Acquire Innovative Laser Technologies
Jun 19, 2017 12:00 pm UTC| Business
OXFORD, Mass., June 19, 2017 -- IPG Photonics Corporation (NASDAQ:IPGP) today announced that it has signed a definitive agreement to acquire Innovative Laser Technologies (ILT), for $40 million in cash. ILT’s expertise...
T2 Biosystems Chief Scientific Officer Tom Lowery to Present at BIO 2017 Convention
Jun 19, 2017 12:00 pm UTC| Business
LEXINGTON, Mass., June 19, 2017 -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, today announced that its chief scientific officer,...
Jun 19, 2017 12:00 pm UTC| Business
DUBLIN, Ireland, June 19, 2017 -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and...
Altimmune to Provide Corporate Update at the BIO International Convention
Jun 19, 2017 12:00 pm UTC| Business
GAITHERSBURG, Md., June 19, 2017 -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced that Bill Enright, President and Chief Executive Officer of Altimmune, will present a...